| Literature DB >> 36132691 |
Mohammadreza Behi1,2, Leila Gholami3, Sina Naficy1, Stefano Palomba2,4, Fariba Dehghani1.
Abstract
Carbon dots (CDs) are a recently synthesised class of carbon-based nanostructures known as zero-dimensional (0D) nanomaterials, which have drawn a great deal of attention owing to their distinctive features, which encompass optical properties (e.g., photoluminescence), ease of passivation, low cost, simple synthetic route, accessibility of precursors and other properties. These newly synthesised nano-sized materials can replace traditional semiconductor quantum dots, which exhibit significant toxicity drawbacks and higher cost. It is demonstrated that their involvement in diverse areas of chemical and bio-sensing, bio-imaging, drug delivery, photocatalysis, electrocatalysis and light-emitting devices consider them as flawless and potential candidates for biomedical application. In this review, we provide a classification of CDs within their extended families, an overview of the different methods of CDs preparation, especially from natural sources, i.e., environmentally friendly and their unique photoluminescence properties, thoroughly describing the peculiar aspects of their applications in the biomedical field, where we think they will thrive as the next generation of quantum emitters. We believe that this review covers a niche that was not reviewed by other similar publications. This journal is © The Royal Society of Chemistry.Entities:
Year: 2021 PMID: 36132691 PMCID: PMC9419304 DOI: 10.1039/d1na00559f
Source DB: PubMed Journal: Nanoscale Adv ISSN: 2516-0230
A summary of review articles from the past eight years devoted to the synthesis, photoluminescence (PL) mechanism, and applications of CD
| Authors | Year | Reviewed synopsis | Ref. |
|---|---|---|---|
| Li | 2012 | This article focuses on the synthesis of CDs, surface functionalization, PL properties, and their applications in photocatalysis, photovoltaic, energy and sensors. Moreover, the photo induced electron transfer ability and light-harvesting capability of CDs are discussed |
|
| Yang | 2013 | This article reviews the hydrothermal, solvothermal, and microwave synthesis of fluorescent CDs and their sensing applications as nanoprobes for ions, organic and biological molecules and target gases. Furthermore, the application of CDs in cell imaging and drug delivery is discussed |
|
| Wang | 2014 | In this article, the progress in the synthesis of CDs is summarized, focusing on various synthesis methods, size control, and modification strategies. Furthermore, the properties and applications of CDs have been reviewed, including their photoelectric properties, luminescent mechanism, and applications in biomedicine, optronics, catalysis, and sensing |
|
| Hong | 2015 | This review article surveys the synthesis, functionalization, and biocompatibility of carbon nanomaterials and their progress in biological imaging and nanomedicine therapy |
|
| Zheng | 2015 | This paper explores the problems associated with CDs, such as the broad emission spectrum, low quantum yield, and low-yield synthesis methods. It is concluded that most CDs emit in the green or blue spectral range. Meanwhile, excitation and emission at long wavelengths are particularly desired for deep tissue imaging |
|
| Zhu | 2015 | This review article explores the synthesis methods and properties of three CDs and the advances in elucidating the PL mechanism of these materials |
|
| Cayuela | 2016 | In this review, the decorated fluorescent dots serve as central nano scaffolds, which helps assemble and display one or more functions, such as targeting or sensing biomolecules and bio-imaging. They concluded that the efforts should be directed to design a multifunctional platform by controlling drug release, targeting, monitoring pharmacokinetics, and biodistribution. Although they are considered promising multi-modal phototherapeutic agents for enhanced cancer therapy in future clinical applications, further investigations are needed, particularly for carbon-based dots |
|
| Reiss | 2016 | This article reviews the synthesis of semiconductor nanocrystals and colloidal quantum dots in organic solvents, emphasizing earth-abundant and toxic heavy metal-free compounds |
|
| Zhou | 2017 | In this review article, the progress in imaging using CDs doped with heteroatoms (X-CDs) is summarized. The design strategies, doping species, properties, PL mechanism, and bioimaging applications are discussed |
|
| Namdari | 2017 | This article describes the novel application of CDs for |
|
| Tuerhong | 2017 | This review article highlights the progress made in polymer-based CDs, including the effect of polymers on the formation of CDs, their fabrication, and applications |
|
| Tao | 2017 | This review article focuses on polymer-based carbon dots and summarizes their formation process, properties, and PL mechanism |
|
| Chen | In this article, graphene quantum dot-based nanohybrid materials are discussed in regard to their method of synthesis, physicochemical properties, and specific biocompatibility characteristics compared to other nanostructured materials |
| |
| Das | 2018 | This review article summarizes the synthesis methods of CDs made from natural sources. These include electrochemical synthesis, microwave, confined pyrolysis, or solution chemistry |
|
| Zhang | 2018 | This review paper discusses the recent progress in the synthesis, characterization, and applications of CDs made from natural sources. The applications include bioimaging, solar cells, sensors, and catalysis |
|
| Chan | 2018 | This review illustrates a series of various carbon dot-based sensors in terms of their sensing mechanism. In addition, these sensors' sensitivity and selectivity for detecting different elements comprising of heavy metals, cations, onions, and so forth are investigated |
|
| Ghosal | 2019 | This review focuses on current methods of CDs preparation. It also evaluates the impact of synthesis methods and the fluorescence properties of CDs in the biomedical area, specifically focused on therapeutic platforms |
|
| Wagner | 2019 | In this review paper, recent signs of progress and obstacles in the design of quantum carbon dot are discussed, and various approaches to improving the quantum yield stability by bioconjugation clearance are explained. Also, it provides a detailed overview of the distribution and toxicity of quantum dots |
|
| Yuan | 2019 | In this review, in addition to general information about the synthesis methods of CDs and their optical properties, new insights are given at room temperature phosphorescence, delayed fluorescence properties, and their optoelectronic applications, such as light-emitting diodes, lasing, solar cells, and photodetectors. Additionally, obstacles faced in materializing these applications are discussed |
|
| Su | 2020 | This article provides a comprehensive scope of CDs application in the bioimaging of normal and cancer stem cells and tumour cells, two-photon fluorescence imaging, |
|
| Koutsogiannis | 2020 | This article focuses on the effects of CDs development methods and its bioimaging properties as a cancer theranostic agent |
|
| Goreham | 2020 | This review article explicitly emphasizes the modifiable properties of CDs as a labelling agent for particularly extracellular vesicles tracking and their application in bioimaging and biosensing |
|
| Wang | 2020 | In this article, the properties of semiconductor quantum dots produced |
|
| Liu | 2020 | In this article, the authors evaluate and compare the properties of traditional quantum dots and carbon dots. They also present a bright scheme of physicochemical properties and methods of preparation, along with a novel outlook for the comprehensive identification of traditional quantum dots and carbon dots |
|
Fig. 1The addressable areas of research for CDs.
Fig. 2Illustration of three different types of carbon dots (CDs), from left to right: carbon nanodots (CNDs), graphene quantum dots (GQDs) and polymer dots (PDs).
Fig. 3Schematic illustration of the production routes of CDs: (a) “bottom-up” synthesis, where CDs are prepared from organic molecules or polymers through hydrothermal, calcination, microwave radiation, and not limited to these methods; (b) “top-down” synthesis, where CDs are prepared from larger sized carbon resources through acidic oxidation, hydrothermal cutting, and electrochemical methods.
Different methods for the synthesis of CDs with their specific advantages and disadvantages. BU and TD are abbreviations for bottom-up and top-down approaches, respectively, and QY is the quantum yield
| Synthesis methods | Approach | QY (%) | Advantage | Disadvantage | Reference |
|---|---|---|---|---|---|
| Chemical ablation | BU | 4.34–28 | Wide range of starting materials, most accessible method | Drastic and harsh processing conditions, multiple steps, poor control oversize |
|
| Hydrothermal/solvothermal treatment | BU | 1.1–94.5 | Cost-effective, eco-friendly, non-toxic | Poor control over size, low production yield |
|
| Solid-state thermal treatment | BU and TD | 9–69 | Cost-effective, eco-friendly, non-toxic | Poor control oversize |
|
| Electrochemical carbonization | TD | 15.9–46.2 | Cost-effective, high QY, reasonable control over fabrication parameters | Limited small-molecule precursors, relatively low QY |
|
| Microwave irradiation | BU | 2–44.9 | Rapid process, cost-effective, eco-friendly | Poor control oversize |
|
| Laser ablation | TD | 4–36 | Tunable surface states, rapid process, effective, high production yield | Poor control over size, low QY |
|
Fig. 4Scheme of the various photoluminescence mechanisms and their unique characteristics: (a) SQDs with quantum confinement, where the size-dependent PL, excitation-independent PL has narrow PL band and long lifetimes; (b) CDs/GQDs with quantum confinement, where the size-dependent and excitation-independent PL has a broad PL band and medium lifetimes; (c) CNDs with no quantum confinement, where the size-independent and excitation-dependent PL has a broad PL band and short lifetimes.[49] Adapted from ref. 49 with permission from the Royal Society of Chemistry (Great Britain), copyright 2021.
Fig. 5Proposed PL emission mechanisms of (a) the predominant “red emission” in GO from disorder-induced localized states and (b) the predominant “blue emission” in reduced GO from confined cluster states.[221] Adapted from ref. 221 with permission from John Wiley and Sons, copyright 2021.
Fig. 6Classifications of potential applications of CDs.
Fig. 7Anti-angiogenic effect of CDs. (a) Vascular density observed in buffer (recorded for chick embryos in a chick chorioallantoic membrane (CAM) assay); (b) much lower vascular proliferation upon treatment with CDs. Insets show a graphical representation of the haemoglobin level in the control and sample treated with CDs, adopted and modified from ref. 237. These images were adapted with permission from ref. 237. American Chemical Society, Copyright 2015.
Fig. 8The scheme depicts the preparation of a gene delivery platform using CDs as vehicles. (a) The CDs are prepared through microwave-induced hydrothermal treatment of glycerol and polyethyleneimine. The CDs were incubated with DNA, forming the transfection agent following further condensation; (b) TEM images of negatively stained CDs/pDNA complexes. They were adopted and modified from.[76] These images were adapted with permission from ref. 76. Elsevier, copyright 2021.
Fig. 9CDs synthesised from oligonucleotides precursor as a cellular delivery vehicle. (a) The scheme depicts the hydrothermal synthesis of CDs from purified DNA and employing the CDs for either bioimaging (making use of their fluorescence) or delivery into cells (upon attachment of molecular cargo onto the CDs); (b) DNA–CDs were readily internalized by bacteria and yeast. DNA–CDs entered (b1) E. coli or (b2) S. cerevisiae cells and emitted green signals upon UV irradiation (405 nm) as shown on CFM images.[246] These images were adapted with permission from ref. 246. American Chemical Society, Copyright 2015.
Fig. 10Cell imaging using CDs. (a) Confocal fluorescence microscopy images of CHO cells incubated with amphiphilic CDs embedded within phospholipid small unilamellar vesicles, (a1) bright-field image, (a2) images recorded at an excitation of 405 nm and emission filter 525/30 nm, (a3) excitation of 488 nm and emission filter 525/30 nm, (a4) excitation at 561 nm and emission 641/40 nm. Scale bar is 10 μm;[252] (b) CLSM images of live HL-7702 cells using 0.1 mg mL−1 CDs. (b1) Before and (b2 and b3) after treatment, (b2) with 10−6 M Cu2+ and (b3) 10−5 M Cu2+. Scale bar is 25 μm;[253] (c) confocal fluorescence microscopy images (excitation at 405 nm) of MCF-7 cells incubated with CDs prepared from (c1) metaphenylenediamine, (c2) ortho phenylenediamine, and (c3) paraphenylenediamine. Each CDs label provides a distinct fluorescence emission peak (e.g., distinct colour).[256] These images were adapted with permission from ref. 252, 253 and 256. RSC, Elsevier and John Wiley and Sons. Copyright 2021.
A representative overview of the selected CDs used in imaging and bioimaging along with their synthesis methods, characterization, and application
| Synthetic method | Precursor/reactants | QY (%) | Excitation range (nm) | Emission range (nm) | Max of em @ ex (nm) | Size (nm) | Application | Reference |
|---|---|---|---|---|---|---|---|---|
| Hydrothermal | Bagasse wastes | 12.3 | 330–510 | ∼430–550 |
| 1.8 | Bio-imaging (cancer cell) |
|
| Ultrasound irradiation | Food wastes | 2.8 | 330–405 | ∼410–470 |
| 4 | Bio-imaging (cancer cell) |
|
| Hydrothermal | Folic acid | 58.0 | 325–425 | ∼440–460 |
| 3.5 ± 0.6 | Bio-imaging (cancer cell) |
|
| Hydrothermal | (1) 6- | (1) 6.5 | (1) 350–500 | (1) 490–570 | (1) | 4.2 ± 0.6 | Environmental (solid state lighting) |
|
| (2) 6- | (2) 7.4 | (2) 350–550 | (2) 520–630 | (2) | ||||
| (3) Vitamin B1 + oleic acid | (3) 14.5 | (3) 350–600 | (3) 580–650 | (3) | ||||
| Laser ablation | (1) 1- | (1) 5.0 | 340–520 | ∼410–580 |
| 1.5, 2.9 and 3 | Ionic liquid |
|
| (2) 1- | (2) 19.0 | |||||||
| (3) 1- | (3) 20.0 | |||||||
| Hydrothermal | Poly(vinyl alcohol) (PVA) and ethylenediamine (EDA) | 35.0 | 240–400 | ∼410–465 |
| — | Environmental (solid state lighting) |
|
| Hydrothermal | 4,7,10-Trioxa-1,13-tridecane diamine (TTDDA) and citric acid | 21.0 | 340–500 | ∼430–525 |
| 4 | Bio-imaging (cancer cell) |
|
| Microwave | Latex | — | 460 | 360–520 | 360–520 | 2–8 | Metal sensing and cellular imaging |
|
| Hydrothermal | Citrate and urea | 93 | 400–525 | 535 |
| 2.75 | Bio-imaging (cancer cell) |
|
| Microwave | Tissue paper | — | 200 to 900 | 500 |
| 4.2 | Determination of glutathione |
|
| Hydrothermal | Pear, avocado, kiwi, and citrate | 20–35 | 470 | 500 |
| 3.98–4.35 | Bio imaging |
|
| Hydrothermal | Linseed | 14.2 | 242–324 | 503 |
| 4–8 | Bio-imaging (cancer cell) |
|
A representative overview of the selected studies of carbon-based nanomaterials including CDs and their applications in chemo-/bio-sensing
| Synthetic method | Precursor/reactants | Excitation range (nm) | Emission range (nm) | Max of em @ ex (nm) | Size (nm) | Sensing application | LOD | Linear range | Analyte | Reference |
|---|---|---|---|---|---|---|---|---|---|---|
| Hydrothermal | 4,7,10-Trioxa-1, TTDDA& citric acid | 340–500 | ∼430–525 |
| 4 | Environmental | 20 nM | — | Copper ion |
|
| Commercial carboxylatedgraphene quantum dot | 353 | ∼457–470 |
| 4.2 ± 0.8 | Medical | 450 pM | 3–54 nM | Epithelial cell adhesion molecule/EpCAM |
| |
| Hydrothermal | Hydrosoluble chitosan | 260–450 | ∼380–510 |
| 3.8 | Environmental | 80 nM | 0–250 μM | Mercury ion |
|
| Hydrothermal | Citric acid and tris | 390–440 | ∼510 |
| 1.5–5 | Medical | 8 nM | 10–70 μM | Hydrogen peroxide |
|
| Hydrothermal | Oleic acid and 1-octadecene | 980 | — | — | 27 ± 2 | Medical | 0.5 pM | — | PCA3/mRNA |
|
| Modified Hummers method | Graphite powder | 494 | 520 |
| 0.8 (thick) | Medical | 3.0 fM | 0.02–100 pM | miRNA-126 |
|
| Commercial carboxyl graphene water dispersion | (1) 485 | (1) 551–620 |
| — | Medical | 2.0 nM, 1.2 nM | — | miRNA-21 |
| |
| (2) 634 | (2) 660–700 |
| miRNA-141 | |||||||
| Commercial graphene oxide | 460 | ∼602 |
| — | Medical | 0.76 nM | 3.7–613 nM | Thrombin |
| |
| Modified Hummer's method | Graphite powder | 495 | ∼520 |
| 2D flakes μm range | Medical | 0.5 nM | — | Cyclin A2 |
|
| Hummer's method | Graphite powder | 480 | ∼521 |
| — | Medical | 2.5 ng mL−1 | 10–150 ng mL−1 | MMP-2 |
|
| Modified Hummers method | Graphite powder | 240 | ∼309 |
| — | Medical | 1.3 nM | 1.3–10 nM | Estriol |
|
| Modified Hummers method | Graphite powder | 300–500 | 455–495 |
| ∼2D (H: 2 nm, L < 50) | Medical | 0.6 10 ng mL−1 | — | IgG |
|
GQD-PEG-aptamer/MoS2 nanocomplex platform.
Co-Doped multifunctional carbon dots (N, Zn-CDs) platform.
NaYF4:Yb,Er upconversion NPs (UCNPs) as emitters and GO as the fluorescence quencher, GO/UCNP/ssDNA sensing platform.
GO/FAM-ssDNA platform as fluorescence sensor based on GO and site-specific DNA cleavage of RsaI endonuclease.
Go-Based fluorescence immunosensor including GO/FAM-anti-miR-21/Cy5-anti-miR-141 ssDNA.
Hybrid GO-OMO sensing platform, GO-RuOMO-aptamers.
Hybrid GO-SWNTs sensing platform, GO/FITC-HAKRRLIF.
The SWNTs was 1D nanomaterial, ϕ = 1.1 nm, length = 50–300 nm.
Hummer's method can be similar to chemical ablation regarding synthesis, regarding using the harsh acidic environment (cutting/oxidation).